Alemu, Getaneh
Nibret, Endalkachew
Munshea, Abaineh
Anegagrie, Melaku
Flores-Chávez, María
Hailu, Tadesse
Amor, Arancha
Article History
Received: 30 May 2025
Accepted: 9 July 2025
First Online: 4 August 2025
Declarations
:
: The study received approval from the Institutional Review Board of Bahir Dar University, Science College (Ref: PRCSVD/514/2015). A permission letter was obtained from the Amhara Public Health Institute, and support letters were secured from zonal health departments, district health and education offices, and selected primary schools and kebele administrations. Informed written consent was obtained from adult participants and the parents/caregivers of child participants, while assent was obtained from children. All participants who tested positive for S. mansoni were treated with the standard dosage of praziquantel (40 mg/kg).
: Not applicable.
: The authors declare that they have no competing interests.